3 - Comment

PMGroup was delighted to be able to hold this year’s Communiqué Awards in person on 7 July at the London Grosvenor House Hotel. The achievements of medical comms consultancies, charities and healthcare communicators were all celebrated at this year’s Awards, hosted by actor and comedian, Stephen Mangan.

This year, the awards included 29 categories, covering healthcare communications and medical affairs, along with individual, team and company honours, acknowledging the outstanding contributions made by entrants from all corners of the industry.

Notable winners included the team from Langland, taking home not one but two awards for its entry, Being Bella: An Innovative Approach to Clinical Trial Investigator Engagement, which won the categories for both Excellence in Medical Affairs-Led Scientific Exchange and Innovation in Scientific Communications.

Healthcare Communiquétor for 2022 was posthumously awarded to Rob Dawson for his outstanding contributions to the healthcare communications industry. The award for Healthcare Communications Advocate 2022 was awarded posthumously to Dame Deborah James for her charitable campaigning, challenging of taboos around cancer and her constant #RebelliousHope.

Turn to page 24 to see photos and other exciting details from the night, including a list of winners. A full list of the results can be viewed here: https://www.pmlive.com/awards/communique/previous_winners/communique_awards_2022_results
Congratulations to all our winners, highly commended and finalists!

In this issue, our cover article focuses on achieving communications excellence by targeting the right channel at the right time. Read more about how analysing target audiences to understand their specific content needs will form the foundations of communications excellence on page 32.

Turn to page 16 to read about the pharmaceutical industry’s environmental commitments, and on page 20, we have an article on the Royal Society’s EiR programme and how that can help to drive UK innovation.

Looking ahead, our September issue will look at the benefits of patient support programmes in specific disease areas.

If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/editorial assistants
Fleur Jeffries and Emily Kimber

Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Achieving and celebrating comms excellence